EPHA3

Материал из hpluswiki
Версия от 18:33, 12 мая 2021; OdysseusBot (обсуждение | вклад) (Новая страница: «Ephrin type-A receptor 3 precursor (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein ki...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигации Перейти к поиску

Ephrin type-A receptor 3 precursor (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1) [ETK] [ETK1] [HEK] [TYRO4]

Publications[править]

A high-content cellular senescence screen identifies candidate tumor suppressors, including EPHA3.

Activation of a cellular senescence program is a common response to prolonged oncogene activation or tumor suppressor loss, providing a physiological mechanism for tumor suppression in premalignant cells. The link between senescence and tumor suppression supports the hypothesis that a loss-of-function screen measuring bona fide senescence marker activation should identify candidate tumor suppressors. Using a high-content siRNA screening assay for cell morphology and proliferation measures, we identify 12 senescence-regulating kinases and determine their senescence marker signatures, including elevation of senescence-associated β-galactosidase, DNA damage and p53 or p16 (INK4a) expression. Consistent with our hypothesis, SNP array CGH data supports loss of gene copy number of five senescence-suppressing genes across multiple tumor samples. One such candidate is the EPHA3 receptor tyrosine kinase, a gene commonly mutated in human cancer. We demonstrate that selected intracellular EPHA3 tumor-associated point mutations decrease receptor expression level and/or receptor tyrosine kinase (RTK) activity. Our study therefore describes a new strategy to mine for novel candidate tumor suppressors and provides compelling evidence that EPHA3 mutations may promote tumorigenesis only when key senescence-inducing pathways have been inactivated.

MeSH Terms

  • Cell Line, Tumor
  • Cell Transformation, Neoplastic
  • Cellular Senescence
  • Cyclin-Dependent Kinase Inhibitor p16
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • High-Throughput Screening Assays
  • Humans
  • Models, Molecular
  • Mutation
  • Oligonucleotide Array Sequence Analysis
  • Polymorphism, Single Nucleotide
  • RNA, Small Interfering
  • Receptor Protein-Tyrosine Kinases
  • Receptor, EphA3
  • Signal Transduction
  • Tumor Suppressor Protein p53
  • beta-Galactosidase

Keywords

  • DDR
  • EPHA3/RTK
  • p16INK4a
  • p53
  • senescence
  • tumor suppressor